Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase

Leukemia Research

Volumn 23, Issue 9, 1999, Pages 817-826

  Gale, Robert Peter ^a   Edward Park, Rolla ^b   Dubois, Robert W ^c   Herzig, Geoffrey P ^d   Hocking, William G ^e   Horowitz, Mary M ^f   Keating, Armand ^g   Kempin, Sanford ^h   Linker, Charles A ⁱ   Schiffer, Charles A ^j   Wiernik, Peter H ^k   Weisdorf, Daniel J ^l   Rai, Kanti R ^m  

^a Salick Health Care Inc   (United States)

^b RAND CORPORATION   (United States)

^c Value Health Sciences   (United States)

^d Saint Vincents Comprehensive Cancer Center   (United States)

^e MARSHFIELD CLINIC   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h Desert Comprehensive Cancer Center   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k OUR LADY OF MERCY MEDICAL CENTER   (United States)

^l UNIVERSITY OF MINNESOTA   (United States)

^m LONG ISLAND JEWISH MEDICAL CENTER   (United States)

more..

Author keywords

Bone marrow transplants; Chronic myelogenous leukemia; HLA identical sibling; Interferon

Indexed keywords

BUSULFAN; HYDROXYUREA; INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; HLA MATCHING; HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; ALGORITHMS; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DELPHI TECHNIQUE; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; PROGNOSIS; TISSUE DONORS;

EID: 0032789247     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00097-1     Document Type: Article

References (26)

1. Clift R.A., Applebaum F.R., Thomas E.D. Treatment of chronic myeloid leukemia by marrow transplantation. Blood. 82:1993;1954-1956.
2. Passweg JR, Rowlings PA, Armitage JO, et al. Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry-North America. In: Cecka JM, Teraskaki PI, editors. Clinical Transplants, 1995. UCLA Tissue Typing Laboratory, Los Angeles, CA, 1996;117-27.
3. Lee S.L., Kuntz K.M., Horowitz M.M. et al. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Ann. Intern. Med. 127:1997;1080-1088.
4. Lee S.J., Anasetti C., Horowitz M.M. et al. Initial therapy for chronic myelogenous leukemia: playing the odds. J. Clin. Oncol. 16:1998;2897-2903.
5. Gale R.P., Hehlman R., Zhang M.-J. et al. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemias. Blood. 91:1998;1810-1819.
6. Buckner C.D., Clift R.A. Timing of allogeneic marrow transplants for patients with chronic myelogenous leukemia. Bone Marrow Transplant. 15 Suppl 1:1995;S203.
7. Goldman J.M., Sydlo R., Horowitz M.M. et al. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood. 82:1993;2235-2238.
8. Gratwohl A., Hermans J., Goldman J.W. et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet. 352:1998;1087-1092.
9. Morton A.J., Gooley T., Hansen J.A. et al. Impact of pretransplant interferon-α (IFN) on outcome of unrelated donor marrow transplants for chronic myelogenous leukemias (CML) in first chronic phase. Blood. 90:1997;123a.
10. Giralt S.A., Kantarjian H.M., Talpaz M. et al. Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia. J. Clin. Oncol. 11:1993;1055.
11. Horowitz MM, Giralt SA, Szydlo R, et al. Effect of prior interferon therapy on outcome of HLA-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in first chronic phase. Blood, 1996; 88:682a, (Abstr 2716).
12. Brook R.H., Chassin M.R., Fink A. et al. A method for the detailed assessment of the appropriateness of medical technologies. Intl. J. Tech. Assess. Health Care. 2:1986;53-56.
13. Jones J., Hunter D. Consensus methods for medical and health services research. Br. Med. J. 311:1986;376-380.
14. Woolf SH. Practice guidelines, a new reality in medicine, I: recent developments; and II. Methods of developing guidelines. Arch Intern Med, 1990; 150: 1811-8, and 1992; 152:946-52.
15. Woolf SH. Practice guidelines, a new reality in medicine, I: recent developments; and II. Methods of developing guidelines. Arch Intern Med, 1990; 150: 1811-8, and 1992; 152:946-52.
16. Park R.E., Fink A., Brook R.H. et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am. J. Publ. Health. 76:1986;766-772.
17. Gale R.P., Park R.E., Dubois R. et al. Delphi-consensus panel analysis of appropriateness of high-dose therapy and bone marrow transplants in acute lymphoblastic leukemia in 1st remission. Leuk. Res. 22:1998;973-981.
18. Gale RP, Park RE, Dubois R, et al. Delphi-consensus panel analysis of appropriateness of high-dose therapy and bone marrow transplants in acute myelogenous leukemia in 1st remission. Leuk Res 1999;23:709-18.
19. Sokal J.E., Cox E.B., Baccarani M. et al. Prognostic discrimination in 'good-risk' chronic granulocytic leukemia. Blood. 63:1984;789-799.
20. Sokal J.E., Baccarani M., Tura S. et al. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood. 66:1985;1326-1335.
21. Breiman L., Friedman J.H., Olshen R.A. et al. Classification and Regression Trees. 1984;75-78 Wadsworth and Brooks, Monterey, CA.
22. Shekelle PG, Chassin MR, Park RE. Evidence for the validity of criteria for performing carotid endarterectomy. Int J Tech Assess Health Care 1998;14:707-27.
23. Kravitz R.L., Laouri M., Kahan J.P. et al. Validity of criteria used for detecting underuse of coronary revascularization. J. Am. Med. Ass. 274:1995;632-638.
24. Selby J.V.B., Fireman B.H., Lundstrom R.J. et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. New Engl. J. Med. 335:1996;1888-1896.
25. Shekelle P.G., Kahan J.P., Bernstein S.J. et al. Reproducibility of the method to identify the overuse and underuse of medical procedures. New Engl. J. Med. 338:1998;1888-1895.
26. Hansen J.A., Gooley T.A., Martin P.J. et al. Bone marrow transplants from unrelated donor for patients with chronic myeloid leukemia. New Engl. J. Med. 338:1998;962-968.